# Calculation of ATP production rates using the Seahorse XF Analyzer

**Authors:** Brandon R Desousa, Kristen KO Kim, Anthony E Jones, Andréa B Ball, Wei Y Hsieh, Pamela Swain, Danielle H Morrow, Alexandra J Brownstein, David A Ferrick, Orian S Shirihai, Andrew Neilson, David A Nathanson, George W Rogers, Brian P Dranka, Anne N Murphy, Charles Affourtit, Steven J Bensinger, Linsey Stiles, Natalia Romero, Ajit S Divakaruni

PMC · DOI: 10.15252/embr.202256380 · EMBO Reports · 2023-08-07

## TL;DR

This paper introduces a method to calculate ATP production rates from live cells using the Seahorse XF Analyzer, enabling direct comparison of energy sources like glycolysis and oxidative phosphorylation.

## Contribution

A novel method to calculate ATP production rates using Seahorse XF Analyzer data and empirical conversion factors.

## Key findings

- The method quantifies bioenergetic changes during macrophage polarization and cancer cell adaptation.
- Substantial ATP utilization changes are detected during neuronal depolarization and T cell receptor activation.
- The method provides a single readout for comparing ATP from oxidative phosphorylation and glycolysis.

## Abstract

Oxidative phosphorylation and glycolysis are the dominant ATP‐generating pathways in mammalian metabolism. The balance between these two pathways is often shifted to execute cell‐specific functions in response to stimuli that promote activation, proliferation, or differentiation. However, measurement of these metabolic switches has remained mostly qualitative, making it difficult to discriminate between healthy, physiological changes in energy transduction or compensatory responses due to metabolic dysfunction. We therefore present a broadly applicable method to calculate ATP production rates from oxidative phosphorylation and glycolysis using Seahorse XF Analyzer data and empirical conversion factors. We quantify the bioenergetic changes observed during macrophage polarization as well as cancer cell adaptation to in vitro culture conditions. Additionally, we detect substantive changes in ATP utilization upon neuronal depolarization and T cell receptor activation that are not evident from steady‐state ATP measurements. This method generates a single readout that allows the direct comparison of ATP produced from oxidative phosphorylation and glycolysis in live cells. Additionally, the manuscript provides a framework for tailoring the calculations to specific cell systems or experimental conditions.

This manuscript details a method to calculate ATP production rates using OCR and ECAR data obtained from the Seahorse XF Analyzer. This generates a single readout measuring real‐time rates of ATP produced from oxidative phosphorylation and glycolysis in live cells.

## Full-text entities

- **Genes:** Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, MRAP (melanocortin 2 receptor accessory protein) [NCBI Gene 56246] {aka B27, C21orf61, FALP, GCCD2, MRAP1}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, OGDH (oxoglutarate dehydrogenase) [NCBI Gene 4967] {aka AKGDH, E1k, E1o, HsOGDH, KGD1, OGDC}, GLS (glutaminase) [NCBI Gene 2744] {aka AAD20, CASGID, DEE71, EIEE71, GAC, GAM}, IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, Cd28 (CD28 antigen) [NCBI Gene 12487], Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) [NCBI Gene 54704] {aka PDH, PDP, PDPC, PDPC 1, PPM2A, PPM2C}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}
- **Diseases:** glioblastoma (MESH:D005909), ASD (MESH:D001321), inflammatory (MESH:D007249), Glioma (MESH:D005910), excitotoxic injury (MESH:D014947), cancer (MESH:D009369), ischemia (MESH:D007511), metabolic dysfunction (MESH:D008659), mitochondrial dysfunction (MESH:D028361)
- **Chemicals:** antimycin A (MESH:D000968), LPS (MESH:D008070), keto acid (MESH:D007651), penicillin (MESH:D010406), fluorocitrate (MESH:C007744), beta-hydroxybutyrate (MESH:D020155), platinum (MESH:D010984), alpha-ketoisocaproic acid (MESH:C013082), NE (MESH:D009356), noradrenaline (MESH:D009638), hydrazine (MESH:C029424), EGTA (MESH:D004533), amino acids (MESH:D000596), HCO3- (MESH:D001639), sucrose (MESH:D013395), ADP (MESH:D000244), carbon (MESH:D002244), rotenone (MESH:D012402), H2SO4 (MESH:C033158), Acid (MESH:D000143), ouabain (MESH:D010042), P (MESH:D010758), 2-DG (MESH:D003847), inorganic phosphate (MESH:D010710), sodium deoxycholate (MESH:D003840), UK5099 (MESH:C043654), streptomycin (MESH:D013307), Indomethacin (MESH:D007213), HCl (MESH:D006851), pentose phosphate (MESH:D010428), malonate (MESH:C030290), Krebs-Henseleit buffer (MESH:C074097), IAA (MESH:D019807), CO2 (MESH:D002245), Pyruvate (MESH:D019289), MK-801 (MESH:D016291), MgCl2 (MESH:D015636), HEPES (MESH:D006531), rosiglitazone (MESH:D000077154), NMDA (MESH:D016202), phenol red (MESH:D010637), ketone bodies (MESH:D007657), paraformaldehyde (MESH:C003043), dichloroacetate (MESH:D003999), salts (MESH:D012492), glucose (MESH:D005947), glutamate (MESH:D018698), CB-839 (MESH:C000593334), succinate (MESH:D019802), fatty acid (MESH:D005227), oligomycin (MESH:D009840), O (MESH:D010100), polystyrene (MESH:D011137), antimycin (MESH:C032456), aminooxyacetate (MESH:D000625), leucine (MESH:D007930), sodium dodecyl sulfate (MESH:D012967), NP-40 (MESH:C010615), NAD+ (MESH:D009243), dexamethasone (MESH:D003907)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), MCF-10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), A431 — Homo sapiens (Human), Skin squamous cell carcinoma, Cancer cell line (CVCL_0037), A549 lung adenocarcinoma — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_WN45), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), MDA-MB231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), H460 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0459), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), RPMI — Homo sapiens (Human), Plasma cell myeloma, Cancer cell line (CVCL_0014), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), BAEC — Bos taurus (Bovine), Finite cell line (CVCL_4690), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959), BT474 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0179)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10561364/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10561364/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC10561364/full.md

---
Source: https://tomesphere.com/paper/PMC10561364